What was the Japanese revenue? and how fast was it growing?
It doesn't even pay for the CEOs salary!
Phase three trials did not meet primary endpoints. But you think we'll see revenue from that soon? Maybe funding for more trials from partnerships yeah.
- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-253
-
-
- There are more pages in this discussion • 171 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.18 |
Change
0.015(1.29%) |
Mkt cap ! $1.347B |
Open | High | Low | Value | Volume |
$1.15 | $1.20 | $1.15 | $4.551M | 3.886M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 98246 | $1.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 19079 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4469 | 1.185 |
5 | 19883 | 1.180 |
3 | 8100 | 1.175 |
2 | 3030 | 1.170 |
1 | 20000 | 1.165 |
Price($) | Vol. | No. |
---|---|---|
1.180 | 41021 | 4 |
1.185 | 6843 | 3 |
1.190 | 62372 | 3 |
1.195 | 62888 | 3 |
1.200 | 132455 | 16 |
Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |